Hak

Italy The Netherlands
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Primary care
  • Respiratory syncytial virus
  • Influenza virus
  • Influenza-like illness/Acute respiratory infection

FLUVAC EV-03

France
|
2016-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Influenza virus
  • Streptococcus pneumoniae
  • Influenza-like illness/Acute respiratory infection
  • Pharmacological intervention
  • Vaccination

Dietz

United Kingdom
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Community
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Influenza-like illness/Acute respiratory infection

Diamantopoulou

Greece
|
2023-2024
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Influenza virus
  • Adenovirus
  • Rhinovirus
  • Enterovirus
  • Human coronavirus NL63
  • Streptococcus pyogenes
  • Influenza-like illness/Acute respiratory infection
  • Diagnostics
  • Point of care tests

De la Matta Farrando

Spain
|
2022-2023
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • Emergency department
  • Influenza-like illness/Acute respiratory infection
  • Diagnostics
  • Point of care tests

CHARISMA

United Kingdom
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Influenza virus
  • Influenza-like illness/Acute respiratory infection
  • Blood sample
  • Nasopharyngeal swab

Cappelli

Italy
|
2021-2023
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Adolescents (12-17 years)
  • Hospital
  • Emergency department
  • Influenza-like illness/Acute respiratory infection